Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
TMDX DEADLINE NOTICE: BFA Law Alerts TransMedics Group, Inc. Investors that Lost Money to Contact the Firm by the April 15 Class Action Deadline
New York, New York-- (Newsfile Corp. - February 25, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...
TransMedics Group (TMDX) Projected to Post Earnings on Thursday
TransMedics Group (NASDAQ:TMDX – Get Free Report) will likely be announcing its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...
Allspring Global Investments Holdings LLC Sells 596,004 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)
Allspring Global Investments Holdings LLC trimmed its stake in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) ...
TMDX Shareholders With Large Losses Should Contact Robbins LLP For Information About The Securities Class Action Against Transmedics Group, Inc.
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
TransMedics: Big Growth And Operational Advantages, Buy This Leading Medical Player
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
Morningstar1d
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
SAN FRANCISCO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant ...
Zacks.com on MSN1d
Curious about TransMedics (TMDX) Q4 Performance? Explore Wall Street Estimates for Key Metrics
In its upcoming report, TransMedics (TMDX) is predicted by Wall Street analysts to post quarterly earnings of $0.18 per share, reflecting an increase of 50% compared to the same period last year.
Business Wire7d
TMDX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...
Morningstar3d
TMDX CLASS ACTION DEADLINE: TransMedics Group, Inc. Investors with Losses are Notified of Ongoing Lawsuit – Contact BFA Law by April 15 Deadline
NEW YORK, Feb. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...
Business Wire10d
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...